Lower Urinary Tract Symptoms Screening Questionnaire

The purpose of this study is to determine the validity of a screening tool which has been designed to detect the presence or absence of lower urinary tract symptoms in the general female population.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cystocele Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Male Urogenital Diseases Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Pelvic Organ Prolapse Prolapse Urinary Bladder Diseases Urogenital Diseases Urologic Diseases

Age range

18 year and older

Sex eligibility

Female

Study type

Observational

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Healthy participants, 18 years of age and older with any gynecological symptoms

Exclusion criteria

Patients with lower urinary tract symptoms and pelvic floor dysfunction

Treatment and study plan

Primary outcomes

Presence or absence of lower urinary tract symptoms in the general female population

Time frame: Five years

To validate the effectiveness of a screening tool in detecting the presence or absence of lower urinary tract symptoms in the general female population.

Sponsors and collaborators

Lead sponsor

Unity Health Toronto

Other

Registry information

Official study title

Lower Urinary Tract Symptoms Screening Questionnaire Validation STudy

Acronym: LUTS-2

Important dates

Study start: 2007
Primary completion: 2007
Study completion: 2011
First posted: Jun 12, 2012
Registry last updated: Feb 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed